1. Home
  2. SRRK vs ATR Comparison

SRRK vs ATR Comparison

Compare SRRK & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$47.76

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo AptarGroup Inc.

ATR

AptarGroup Inc.

HOLD

Current Price

$132.42

Market Cap

7.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
ATR
Founded
2012
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Plastic Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.7B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
SRRK
ATR
Price
$47.76
$132.42
Analyst Decision
Strong Buy
Buy
Analyst Count
13
4
Target Price
$56.17
$170.25
AVG Volume (30 Days)
1.2M
387.8K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
1.56%
EPS Growth
N/A
6.51
EPS
N/A
1.12
Revenue
N/A
$3,777,181,000.00
Revenue This Year
N/A
$5.18
Revenue Next Year
$534.24
$4.98
P/E Ratio
N/A
$115.18
Revenue Growth
N/A
5.42
52 Week Low
$27.07
$103.23
52 Week High
$58.49
$161.98

Technical Indicators

Market Signals
Indicator
SRRK
ATR
Relative Strength Index (RSI) 39.63 63.22
Support Level $45.46 $121.60
Resistance Level $48.23 $132.42
Average True Range (ATR) 2.44 2.85
MACD -1.01 0.02
Stochastic Oscillator 6.24 64.81

Price Performance

Historical Comparison
SRRK
ATR

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Share on Social Networks: